Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-03-13

Clinical Trial Update: Shockwaves Therapy and Botulinum Toxin for the Treatment of Spasticity in Patients With Cerebral Palsy. A Cross Over RCT [Phase 1]

View source ↗

Summary

A Phase 1 cross-over randomized trial evaluating shockwave therapy in combination with botulinum toxin to treat spasticity in cerebral palsy patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Botulinum toxin (botulinum toxin)

Snippet

Sponsor: Xavi Vidal Novellas | Conditions: Spasticity, Cerebral Palsy | Phase 1 | Status: COMPLETED